Chang-Li Wang (Changli Wang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 18

Top Topics

Squamous Cell Carcinoma

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Thoracic cancer

Cancer management and research

Oxidative medicine and cellular longevity

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yulong Chen, Bo Yan, Chang-Li Wang, D Craig Hooper, Zhiyong Yuan, Bo Lu
Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade. Cancer immunology research (2023)
Chaonan Zhu, Shuai Wang, Maogen Zheng, Zhiquan Chen, Guochen Wang, Jun Ma, Bin Zhang, Wuhao Huang, Xiaoyan Sun, Chang-Li Wang
miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 198 (3) (2022)
Shun Lu, Ying Cheng, Jianying Zhou, Mengzhao Wang, Jun Zhao, Baocheng Wang, Gongyan Chen, Jifeng Feng, Zhiyong Ma, Lin Wu, Chang-Li Wang, Kewei Ma, Shucai Zhang, Jun Liang, Yong Song, Jie Wang, Yi-Long Wu, Ang Li, Yizhi Huang, Jianhua Chang
An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870). Therapeutic advances in medical oncology 14 (2022)
Ting Gong, Bin Jia, Chen Chen, Zhen-Fa Zhang, Chang-Li Wang
Clinical analysis of 78 pulmonary sarcomatoid carcinomas with surgical treatment. The Journal of international medical research 50 (10) (2022)
Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu, Lanjun Zhang, Haitao Ma, Qiang Li, Yue Yang, Yongyu Liu, Haiquan Chen, Zhenfa Zhang, Bin Zhang, Chang-Li Wang
Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (34) (2022)
Yue Li, Chen Chen, Hai-Lin Liu, Chen-Guang Li, Zhen-Fa Zhang, Chang-Li Wang
Pazopanib restricts small cell lung cancer proliferation via reactive oxygen species-mediated endoplasmic reticulum stress. Thoracic cancer 13 (17) (2022)
Bin Jia, Ting Gong, Bingsheng Sun, Zhen-Fa Zhang, Diansheng Zhong, Chang-Li Wang
Identification of a DNA damage repair gene-related signature for lung squamous cell carcinoma prognosis. Thoracic cancer 13 (8) (2022)
Lianmin Zhang, Yuan Wang, Yongsheng Sha, Bin Zhang, Rui Zhang, Hua Zhang, Shilei Xu, Hailong Wang, Yue Xu, Yulong Chen, Xiaoliang Zhao, Jianquan Zhu, Zhenfa Zhang, Chang-Li Wang
CITED4 enhances the metastatic potential of lung adenocarcinoma. Thoracic cancer 12 (9) (2021)
Yue Li, Hailin Liu, Yujie Zhao, Dongsheng Yue, Chen Chen, Chenguang Li, Zhen-Fa Zhang, Chang-Li Wang
Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC). Thoracic cancer 12 (20) (2021)
Wuhao Huang, Hua Zhang, Zhiwei Zhang, Bin Zhang, Xiaoyan Sun, Yansong Huo, Yingnan Feng, Pengfei Tian, Huilan Mo, Chang-Li Wang
A prognostic nomogram based on a new classification of combined micropapillary and solid components for stage IA invasive lung adenocarcinoma. Journal of surgical oncology (2021)
Yue Li, Wei Tian, Dongsheng Yue, Chen Chen, Chenguang Li, Zhenfa Zhang, Chang-Li Wang
Bevacizumab-Induced Mitochondrial Dysfunction, Endoplasmic Reticulum Stress, and ERK Inactivation Contribute to Cardiotoxicity. Oxidative medicine and cellular longevity 2021 (2021)
Yu-Chen Ma, Peng-Fei Tian, Zhi-Peng Chen, Dong-Sheng Yue, Cui-Cui Liu, Chen-Guang Li, Chen Chen, Hua Zhang, Hai-Lin Liu, Zhen-Fa Zhang, Liang Chen, Bin Zhang, Chang-Li Wang
Urinary malate dehydrogenase 2 is a new biomarker for early detection of non-small-cell lung cancer. Cancer science 112 (6) (2021)
Xiaoliang Zhao, In-Kyu Kim, Bhaskar Kallakury, Joeffrey J Chahine, Eiji Iwama, Mariaelena Pierobon, Emanuel Petricoin, Justine N McCutcheon, Yu-Wen Zhang, Shigeki Umemura, Vincent Chen, Chang-Li Wang, Giuseppe Giaccone
Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation. Molecular oncology 15 (4) (2021)
Sheng-Guang Wang, Bin Zhang, Chen-Guang Li, Jian-Quan Zhu, Bing-Sheng Sun, Chang-Li Wang
Sorting and gene mutation verification of circulating tumor cells of lung cancer with epidermal growth factor receptor peptide lipid magnetic spheres. Thoracic cancer 11 (10) (2020)
Lu Yang, Chong Pang, Fei Xu, Guangjian Yang, Hai-Yan Xu, Chang-Li Wang, Yan Wang
Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery. Cancer management and research 12 (2020)
Wei-Ran Liu, Bin Zhang, Chen Chen, Yue Li, Xin Ye, Dong-Jiang Tang, Jun-Cheng Zhang, Jing Ma, Yan-Ling Zhou, Xian-Jun Fan, Dong-Sheng Yue, Chen-Guang Li, Hua Zhang, Yu-Chen Ma, Yan-Song Huo, Zhen-Fa Zhang, Shu-Yu He, Chang-Li Wang
Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer. Thoracic cancer 11 (11) (2020)
Chang Liu, Hua Zhang, Qi Qi, Bin Zhang, Dongsheng Yue, Chang-Li Wang
The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer. Thoracic cancer 11 (4) (2020)
Jinfang Zhu, Weiran Liu, Chen Chen, Hua Zhang, Dongsheng Yue, Chenguang Li, Lianmin Zhang, Liuwei Gao, Yansong Huo, Chang Liu, Giuseppe Giaccone, Bin Zhang, Chang-Li Wang
TPP1 OB-fold domain protein suppresses cell proliferation and induces cell apoptosis by inhibiting telomerase recruitment to telomeres in human lung cancer cells. Journal of cancer research and clinical oncology 145 (6) (2019)